We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Hopes New OGD Director Supports Fees, Clears Backlog
GPhA Hopes New OGD Director Supports Fees, Clears Backlog
March 16, 2010
The Generic Pharmaceutical Association (GPhA) expressed hope that the next permanent director of the FDA’s Office of Generic Drugs (OGD) makes clearing
the ANDA backlog and establishing generic user fees a top priority.